Cargando…

Correlates of polyneuropathy in Parkinson’s disease

OBJECTIVE: Previous studies in Parkinson’s disease (PD) patients have demonstrated a high prevalence of polyneuropathy (PNP) and pronounced alpha‐Synuclein pathology in dermal nerve fibers already at early disease stages. The aim of this study was to analyze associations between the prevalence and s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kühn, Eva, Averdunk, Paulina, Huckemann, Sophie, Müller, Katharina, Biesalski, Anne‐Sophie, Hof zum Berge, Florian, Motte, Jeremias, Fisse, Anna Lena, Schneider‐Gold, Christiane, Gold, Ralf, Pitarokoili, Kalliopi, Tönges, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545593/ https://www.ncbi.nlm.nih.gov/pubmed/32940017 http://dx.doi.org/10.1002/acn3.51182

Ejemplares similares

Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson's disease
por: Huckemann, Sophie, et al.
Publicado: (2023)

Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Prevalence and Characteristics of Polyneuropathy in Atypical Parkinsonian Syndromes: An Explorative Study
por: Rohmann, Rachel, et al.
Publicado: (2021)

Nerve Echogenicity in Polyneuropathies of Various Etiologies—Results of a Retrospective Semi-Automatic Analysis of High-Resolution Ultrasound Images
por: Erdmann, Anke, et al.
Publicado: (2022)

Nerve Ultrasound Distinguishes Non-Inflammatory Axonal Polyneuropathy From Inflammatory Polyneuropathy With Secondary Axonal Damage
por: Brünger, Jil, et al.
Publicado: (2022)

Corneal inflammatory cell infiltration predicts disease activity in chronic inflammatory demyelinating polyneuropathy
por: Motte, Jeremias, et al.
Publicado: (2021)

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases
por: Motte, Jeremias, et al.
Publicado: (2019)

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Evaluation of the EFNS/PNS diagnostic criteria in a cohort of CIDP patients
por: Athanasopoulos, Diamantis, et al.
Publicado: (2021)

Serum neurofilament light chain as outcome marker for intensive care unit patients
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study
por: Motte, Jeremias, et al.
Publicado: (2021)

Maintenance therapy with subcutaneous immunoglobulin in a patient with immune‐mediated neuropathic postural tachycardia syndrome
por: Pitarokoili, Kalliopi, et al.
Publicado: (2021)

Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
por: Ambrosius, Björn, et al.
Publicado: (2017)

Longitudinal study on nerve ultrasound and corneal confocal microscopy in NF155 paranodopathy
por: Athanasopoulos, Diamantis, et al.
Publicado: (2020)

Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
por: Grüter, Thomas, et al.
Publicado: (2023)

Data-driven subtyping of Parkinson’s disease: comparison of current methodologies and application to the Bochum PNS cohort
por: Chen, Qiang, et al.
Publicado: (2023)

The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: results from the German INHIBIT register
por: Hieke, Alina, et al.
Publicado: (2022)

Treatment of an acute motor and sensory axonal neuropathy with propionate in a 33-year-old male
por: Yoon, Min-Suk, et al.
Publicado: (2018)

Trigemino-autonomic headache and Horner syndrome as a first sign of granulomatous hypophysitis
por: Motte, Jeremias, et al.
Publicado: (2017)

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats
por: Motte, Jeremias, et al.
Publicado: (2018)

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

High-resolution nerve ultrasound and magnetic resonance neurography as complementary neuroimaging tools for chronic inflammatory demyelinating polyneuropathy
por: Pitarokoili, Kalliopi, et al.
Publicado: (2018)

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Immunomodulatory and anti-oxidative effect of the direct TRPV1 receptor agonist capsaicin on Schwann cells
por: Grüter, Thomas, et al.
Publicado: (2020)

Novel variants in a patient with late-onset hyperprolinemia type II: diagnostic key for status epilepticus and lactic acidosis
por: Motte, Jeremias, et al.
Publicado: (2019)

Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis
por: Klimas, Rafael, et al.
Publicado: (2021)

P-41 The impact of the SARS-CoV-2-pandemic on patients with chronic inflammatory neuropathies: Results from the German INHIBIT register
por: Hieke, A., et al.
Publicado: (2023)

Phoenix from the ashes: dramatic improvement in severe late-onset methylenetetrahydrofolate reductase (MTHFR) deficiency with a complete loss of vision
por: Biesalski, Anne-Sophie, et al.
Publicado: (2021)

Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection
por: Pitarokoili, Kalliopi, et al.
Publicado: (2015)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Update on CSF Biomarkers in Parkinson’s Disease
por: Kwon, Eun Hae, et al.
Publicado: (2022)

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement
por: Hartelt, Elke, et al.
Publicado: (2020)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020)

Quantification of individual remyelination during short-term disease course by synthetic magnetic resonance imaging
por: Schneider, Ruth, et al.
Publicado: (2022)

Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5etmasgb7tu5gv7605d05c2s2i